abstract |
The present invention is directed to peptide analogues of Exendin-3 and Exendin-4 and pharmaceutically-acceptable salts thereof, to methods of using such analogues to treat mammals and to pharmaceutical compositions containing said analogues and/or pharmaceutically-acceptable salts thereof. |